{"entity":{"type":"insider","cik":"0001687312","url":"/insider/0001687312","json_url":"/insider/0001687312.json","name":"Pillar Pharmaceuticals V LP","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":2,"first":"2019-11-08","last":"2020-02-26","span_basis":"filed_date"},"name_variants":[{"name":"Pillar Pharmaceuticals V LP","source":"filing","n_filings":2,"first_seen":"2019-11-08","last_seen":"2020-02-26"}],"transactions":[{"id":2592244,"accession":"0000899243-20-005917","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-005917","line_url":"/filing/0000899243-20-005917#line-3","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals V LP; Pillar Pharmaceuticals III, L.P.; Pillar Partners Foundation, L.P.; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals 6, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.; Umari Abude","owner_display_name":"Pillar Pharmaceuticals V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17250.0,"shares_display":"17,250","price_per_share":1.7645,"price_display":"1.76","price_state":"stated","total_value":30437.625,"total_display":"30,437.62","total_whole":"30,438","shares_owned_after":3254442.0,"shares_owned_after_display":"3,254,442","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-01-29","filed_date":"2020-02-26","scope":"insider"},{"id":2592238,"accession":"0000899243-20-005917","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-005917","line_url":"/filing/0000899243-20-005917#line-2","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals V LP; Pillar Pharmaceuticals III, L.P.; Pillar Partners Foundation, L.P.; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals 6, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.; Umari Abude","owner_display_name":"Pillar Pharmaceuticals V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12532.0,"shares_display":"12,532","price_per_share":1.762,"price_display":"1.76","price_state":"stated","total_value":22081.384,"total_display":"22,081.38","total_whole":"22,081","shares_owned_after":3271692.0,"shares_owned_after_display":"3,271,692","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-01-28","filed_date":"2020-02-26","scope":"insider"},{"id":2592235,"accession":"0000899243-20-005917","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-005917","line_url":"/filing/0000899243-20-005917#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals V LP; Pillar Pharmaceuticals III, L.P.; Pillar Partners Foundation, L.P.; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals 6, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Pillar Pharmaceuticals II, L.P.; Umari Abude","owner_display_name":"Pillar Pharmaceuticals V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":1.77,"price_display":"1.77","price_state":"stated","total_value":26550.0,"total_display":"26,550.00","total_whole":"26,550","shares_owned_after":3284224.0,"shares_owned_after_display":"3,284,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-01-27","filed_date":"2020-02-26","scope":"insider"},{"id":7909824,"accession":"0000899243-19-027012","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-19-027012","line_url":"/filing/0000899243-19-027012#line-3","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals V LP; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals 6, L.P.; Pillar Partners Foundation, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Umari Abude; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":2.44,"price_display":"2.44","price_state":"stated","total_value":21960.0,"total_display":"21,960.00","total_whole":"21,960","shares_owned_after":3299224.0,"shares_owned_after_display":"3,299,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-08","filed_date":"2019-11-08","scope":"insider"},{"id":7909821,"accession":"0000899243-19-027012","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-19-027012","line_url":"/filing/0000899243-19-027012#line-2","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals V LP; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals 6, L.P.; Pillar Partners Foundation, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Umari Abude; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":2.45,"price_display":"2.45","price_state":"stated","total_value":24500.0,"total_display":"24,500.00","total_whole":"24,500","shares_owned_after":3308224.0,"shares_owned_after_display":"3,308,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-07","filed_date":"2019-11-08","scope":"insider"},{"id":7909818,"accession":"0000899243-19-027012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-027012","line_url":"/filing/0000899243-19-027012#line-1","is_derivative":false,"issuer_cik":"0000861838","issuer_name":"IDERA PHARMACEUTICALS, INC.","issuer_ticker":"IDRA","issuer_name_source":null,"issuer_url":"/issuer/0000861838","owner_cik":null,"owner_name":"Pillar Pharmaceuticals V LP; Pillar Pharmaceuticals IV, L.P.; Pillar Pharmaceuticals 6, L.P.; Pillar Partners Foundation, L.P.; ZEIN YOUSSEF EL; Pillar Pharmaceuticals III, L.P.; Pillar Pharmaceuticals I LP; Pillar Invest Corp; Umari Abude; Pillar Pharmaceuticals II, L.P.","owner_display_name":"Pillar Pharmaceuticals V LP","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":2.4956,"price_display":"2.50","price_state":"stated","total_value":249560.0,"total_display":"249,560.00","total_whole":"249,560","shares_owned_after":3318224.0,"shares_owned_after_display":"3,318,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-11-06","filed_date":"2019-11-08","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000861838","name":"IDERA PHARMACEUTICALS, INC.","url":"/issuer/0000861838","role":"Ten percent owner","n_filings":2,"first_seen":"2019-11-08","last_seen":"2020-02-26"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001687312","retrieved_at":"2026-08-24T02:59:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}